[1]
|
Epi-Informatics
2016
DOI:10.1016/B978-0-12-802808-7.00013-7
|
|
|
[2]
|
Epi-Informatics
2016
DOI:10.1016/B978-0-12-802808-7.00012-5
|
|
|
[3]
|
Epi-Informatics
2016
DOI:10.1016/B978-0-12-802808-7.00002-2
|
|
|
[4]
|
Web-based 3D-visualization of the DrugBank chemical space
Journal of Cheminformatics,
2016
DOI:10.1186/s13321-016-0138-2
|
|
|
[5]
|
Similarity Mapplet: Interactive Visualization of the Directory of Useful Decoys and ChEMBL in High Dimensional Chemical Spaces
Journal of Chemical Information and Modeling,
2015
DOI:10.1021/acs.jcim.5b00182
|
|
|
[6]
|
Similarity Mapplet: Interactive Visualization of the Directory of Useful Decoys and ChEMBL in High Dimensional Chemical Spaces
Journal of Chemical Information and Modeling,
2015
DOI:10.1021/acs.jcim.5b00182
|
|
|
[7]
|
Discovery and development of DNA methyltransferase inhibitors using in silico approaches
Drug Discovery Today,
2015
DOI:10.1016/j.drudis.2014.12.007
|
|
|
[8]
|
Evidence-Based Validation of Herbal Medicine
2015
DOI:10.1016/B978-0-12-800874-4.00021-0
|
|
|
[9]
|
Epigenetic Technological Applications
2015
DOI:10.1016/B978-0-12-801080-8.00013-2
|
|
|
[10]
|
Activity landscape of DNA methyltransferase inhibitors bridges chemoinformatics with epigenetic drug discovery
Expert Opinion on Drug Discovery,
2015
DOI:10.1517/17460441.2015.1073257
|
|
|
[11]
|
Epigenetic relevant chemical space: a chemoinformatic characterization of inhibitors of DNA methyltransferases
RSC Adv.,
2015
DOI:10.1039/C5RA19611F
|
|
|
[12]
|
Balancing novelty with confined chemical space in modern drug discovery
Expert Opinion on Drug Discovery,
2014
DOI:10.1517/17460441.2014.872624
|
|
|
[13]
|
Cyclic Systems Distribution Along Similarity Measures: Insights for an Application to Activity Landscape Modeling
Molecular Informatics,
2013
DOI:10.1002/minf.201200127
|
|
|
[14]
|
Diversity-Oriented Synthesis
2013
DOI:10.1002/9781118618110.ch10
|
|
|
[15]
|
Cyclic Systems Distribution Along Similarity Measures: Insights for an Application to Activity Landscape Modeling
Molecular Informatics,
2013
DOI:10.1002/minf.201200127
|
|
|
[16]
|
Molecular Modeling Studies of the Novel Inhibitors of DNA Methyltransferases SGI-1027 and CBC12: Implications for the Mechanism of Inhibition of DNMTs
PLoS ONE,
2013
DOI:10.1371/journal.pone.0062152
|
|
|
[17]
|
Chemoinformatic Analysis of GRAS (Generally Recognized as Safe) Flavor Chemicals and Natural Products
PLoS ONE,
2012
DOI:10.1371/journal.pone.0050798
|
|
|
[18]
|
Interrogating Novel Areas of Chemical Space for Drug Discovery using Chemoinformatics
Drug Development Research,
2012
DOI:10.1002/ddr.21034
|
|
|
[19]
|
CASE Plots for the Chemotype‐Based Activity and Selectivity Analysis: A CASE Study of Cyclooxygenase Inhibitors
Chemical Biology & Drug Design,
2012
DOI:10.1111/cbdd.12019
|
|
|
[20]
|
CASE Plots for the Chemotype-Based Activity and Selectivity Analysis: A CASE Study of Cyclooxygenase Inhibitors
Chemical Biology & Drug Design,
2012
DOI:10.1111/cbdd.12019
|
|
|
[21]
|
Interrogating Novel Areas of Chemical Space for Drug Discovery using Chemoinformatics
Drug Development Research,
2012
DOI:10.1002/ddr.21034
|
|
|
[22]
|
Expanding the medicinally relevant chemical space with compound libraries
Drug Discovery Today,
2012
DOI:10.1016/j.drudis.2012.04.001
|
|
|
[23]
|
Molecular Scaffold Analysis of Natural Products Databases in the Public Domain
Chemical Biology & Drug Design,
2012
DOI:10.1111/cbdd.12011
|
|
|
[24]
|
Molecular Scaffold Analysis of Natural Products Databases in the Public Domain
Chemical Biology & Drug Design,
2012
DOI:10.1111/cbdd.12011
|
|
|